Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients

NCT05311852 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

34

Enrollment

NETWORK

Sponsor class

Conditions

Fatigue
Cognitive Deficit
COVID-19
Neurophysiologic Abnormality

Interventions

DIETARY_SUPPLEMENT: palmitoylethanolamide co-ultramicronized with antioxidant flavonoid luteolin (PEA-LUT)
DIETARY_SUPPLEMENT: Placebo

Sponsor

Department of Neurorehabilitation, Hospital of Vipiteno-Sterzing (BZ) Italy

Collaborators

[object Object]